Outset Medical reported a 6% increase in total revenue for the first quarter of 2025, reaching $29.8 million. The company saw significant growth in recurring revenue (consumables and services), which increased by 20% to $22.7 million. Gross margin improved to 37.2% on a GAAP basis and 37.6% on a non-GAAP basis. Net loss decreased significantly compared to the prior year, and net cash used in operating activities declined by 44%.
Total revenue for Q1 2025 was $29.8 million, a 6% increase year-over-year.
Recurring revenue from consumables and services grew 20% to $22.7 million.
GAAP gross margin improved to 37.2% from 29.2% in Q1 2024.
Net loss per share improved to ($3.66) from ($11.77) in Q1 2024.
Outset Medical reiterated its full-year 2025 revenue guidance and non-GAAP gross margin guidance, and expects to significantly reduce cash usage compared to 2024.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance